Emre Yekedüz

Harvard University — United States

Medicine · Health Sciences

12h-index590citations135works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(38), Cancer Immunotherapy and Biomarkers(33), Cancer Genomics and Diagnostics(23), Prostate Cancer Treatment and Research(15), Pancreatic and Hepatic Oncology Research(14)

Publications135 total

Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of <i>NF2</i>
Clinical Cancer Research·2026Open Access
Sequential use of targeted radioligand therapies in metastatic castration-resistant prostate cancer: A case report and systematic review
Critical Reviews in Oncology/Hematology·2025
Global inequities in the access to systemic prostate cancer therapies: A comprehensive global analysis and implications
European Urology Open Science·2025Open Access
5Integrative clinical, genomic, transcriptomic, and immunopathologic characterization of circulating KIM-1 in metastatic RCC
The Oncologist·2025Open Access
Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis
ESMO Open·2025Open Access
39Intratumoral viral transcriptomic signatures stratify immune phenotypes and clinical outcomes in renal cell carcinoma (RCC)
The Oncologist·2025Open Access
Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration‐Sensitive Prostate Cancer
The Prostate·2025
2601P Peripheral and tumor cytokines in exceptional responders to immunotherapy: Results from a phase III trial
Annals of Oncology·2025
3095P ERBB2 mutations as potential predictors of poor outcomes in patients (pts) treated with enfortumab vedotin (EV): The impact of genomic alterations (GAs) beyond NECTIN-4
Annals of Oncology·2025
132P Genomic determinants of leukocyte homeostasis predict responses to immune checkpoint blockade (ICB) monotherapy versus combination therapy in patients (pts) with cancer
Annals of Oncology·2025
WITHDRAWN: 2666eP Genomic determinants of primary resistance to immune checkpoint inhibition in metastatic renal cell carcinoma
Annals of Oncology·2025
WITHDRAWN: 3120eP Brain metastasis (BM) from bladder cancer (BCa) in the era of Antibody-Drug Conjugates (ADCs): Impact on survival from a large cohort
Annals of Oncology·2025
Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma
BMC Cancer·2025· 1 citedOpen Access
Enhancing outcomes in mCRPC: the impact of androgen receptor inhibitor sequencing before 177Lu-PSMA-617 therapy
The Oncologist·2025· 1 citedOpen Access
Role of immune check point inhibitor rechallenge in metastatic renal cell carcinoma
Kidney Cancer·2025Open Access
Predictive Value of Incidental Cross‐Sectional Imaging for Prediction of Skeletal Events in Patients With Prostate Cancer
Cancer Diagnosis & Prognosis·2025Open Access
The impact of smoking on nivolumab outcomes in renal cell carcinoma: real-world data from the Turkish Oncology Group Kidney Cancer Consortium
The Oncologist·2025Open Access
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study
Immunotherapy·2025
Comorbidity Burden and Effectiveness of Immunotherapy in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer·2025· 1 cited
Landscape of genomic alterations in genes implicated in the regulation of hypoxia inducible factor (HIF) signaling: A pooled analysis of two pan-cancer cohorts.
Journal of Clinical Oncology·2025
page 1 of 7Next →

Frequent Co-authors

Yüksel Ürün(40), Güngör Utkan(15), Mehmet Alı Nahıt Şendur(11), Saadettin Kılıçkap(10), Satı Coşkun Yazgan(9), Hakan Akbulut(9), Nuri Karadurmuş(8), Deniz Tural(8), Çağatay Arslan(8), Hatice Bölek(8), Cihan Erol(7), Özlem Nuray Sever(7), Toni K. Choueiri(7), Elif Berna Köksoy(7), Satı Coşkun Yazgan(7), Güngör Utkan(6), Serdar Karakaya(6), Nihan Şentürk Öztaş(6), Ahmet Küçükarda(6), Orçun Can(6)